Strontium Salicylate
Active ingredient
Sold as D-30
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Sublingual
- Markets covered
- 1
- Products on record
- 1
- FDA reports (12 mo)
- 27
Overview
Plain-language summary, compiled from the cited regulatory records
Strontium Salicylate is an active ingredient indicated for stiffness in joints and muscles [1]. It is available under various brand names, including D-30 [1].
In the past 12 months, there have been 27 adverse event reports associated with this ingredient [2]. The most frequently reported reactions include eye pain, death, diarrhea, eye irritation, and foreign body sensation in eyes [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | January 13, 2025 |
USUnited States· FDA
1 product
Uses
INDICATIONS
Stiffness in joints and muscles.
How to take
Sources & citations
- [1]FDA DailyMed · 0e74e654-4bda-49… · revised January 13, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.